Multiple ulcerative colitis-associated aseptic abscesses successfully treated with infliximab: a case report

Clin J Gastroenterol. 2023 Aug;16(4):537-542. doi: 10.1007/s12328-023-01807-9. Epub 2023 Apr 25.

Abstract

Aseptic abscesses are rare extraintestinal manifestations of inflammatory bowel disease. Herein, we present the case of a 69-year-old female patient with ulcerative colitis in whom multiple aseptic abscesses were successfully treated with infliximab. Aseptic abscesses associated with ulcerative colitis are difficult to differentiate from infectious abscesses. In the present case, we reached a diagnosis of aseptic abscesses associated with ulcerative colitis as antibiotics were ineffective and repeated Gram stains and cultures of blood and abscess were negative. Aseptic abscesses are commonly found in the spleen, lymph nodes, liver, and skin; however, in the present case, the periosteum was the major site. Prednisolone is often effective for aseptic abscesses; however, the present patient was initially treated with a combination of 40 mg/day of prednisolone and granulocyte and monocyte adsorption apheresis, with inadequate effect. Infliximab was administered as the patient was steroid-resistant, with strong effect. Subsequently, infliximab treatment has been continued, with no recurrence after 2 years. However, as there have been reports of cases of recurrence even after remission with treatment, careful follow-up in the future is therefore necessary.

Keywords: Aseptic abscess; Granulocyte and monocyte adsorption apheresis; Infliximab; Steroid-resistant; Ulcerative colitis.

Publication types

  • Case Reports

MeSH terms

  • Abscess / complications
  • Abscess / etiology
  • Aged
  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / drug therapy
  • Female
  • Humans
  • Inflammatory Bowel Diseases* / complications
  • Infliximab / therapeutic use
  • Prednisolone

Substances

  • Infliximab
  • Prednisolone